UICC study group on basic and clinical cancer research: Cancer-suppressing genes

✍ Scribed by Max M. Burger; Carlo M. Croce

• Publisher: John Wiley and Sons
• Year: 1990
• Tongue: French
• Weight: 401 KB
• Volume: 45
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.2910450202

✦ Synopsis

Cancer-suppressing systems have been considered by pathologists and oncologists alike over the last 3 decades, and for several years immune surveillance was in the lime-light. Cancer-suppressing genes, however, have only recently been pinpointed in the aftermath of the bustle of activity set off by the isolation of oncogenes. The study of both oncogenes and cancer-suppressing genes, or so-called anti-oncogenes, should lead the way to phenotypic insight into tumorigenesis.

It is the purpose of these Study Group Meetings, which are organized by the UICC Tumor Biology Program, to establish the basis for possible clinical application founded on molecular concepts. For this purpose some clinicians and pathologists are regularly invited to these meetings, although each time it is difficult to find 4 to 5 clinicians who are treating patients daily and who can also follow the jargon of molecular cancer research. These difficulties should, however, not prevent us from continuing and amplifying such interdisciplinary efforts since there are few better ways of progressing in relevant cancer research, even if the advance consists only in the communication of novel concepts and approaches which may fall on fertile soil on either side.

'This meeting was sponsored by CIBA-GEIGY, Basel, Switzerland. The Tumor Biology Program of the UICC and the participants express their gratitude for the unselfish support and low-key presence of the sponsor.